Position in CGON
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$209,604 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
8 quarters on record
Common Shares in CGON Over Time
Shares Held
Position Value (USD)
Derivatives in CGON
reported options exposure · as of Jun 30, 2026CallValue
$6,557,915
CallShares
92,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in CGON
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,557,915 | 92,300 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $3,864,528 | 57,100 | Put | Defined | 2026-05-12 | |
| 2026-03-31 | $209,604 | 3,097 | Shares | Defined | 2026-05-12 | |
| 2026-03-31 | $2,098,080 | 31,000 | Call | Defined | 2026-05-12 | |
| 2025-12-31 | $2,756,928 | 66,400 | Put | Defined | 2026-02-12 | |
| 2025-12-31 | $1,689,864 | 40,700 | Call | Defined | 2026-02-12 | |
| 2025-09-30 | $418,912 | 10,400 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $551,836 | 13,700 | Call | Defined | 2025-11-14 | |
| 2024-12-31 | $576,468 | 20,100 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $1,759,862 | 61,362 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $7,393,231 | 195,951 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $1,816,884 | 57,551 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $3,351,896 | 76,353 | Shares | Defined | 2024-05-16 | |
| No filing history on record for this holder in this stock. | ||||||